Faculty and Disclosures
Program Chair
Rodica Busui, MD, PhD
Jordan Schnitzer Chair in Diabetes
Professor of Medicine and Division Head, Endocrinology, Diabetes and Clinical Nutrition
Director, Harold Schnitzer Diabetes Center, Oregon Health & Science University
Faculty
James Januzzi, MD
Hutter Family Professor of Medicine, Harvard Medical School
Cardiologist, Massachusetts General Hospital, Harvard Medical School,
Maria Luiza Caramori, MD, MSc, PhD
Endocrinology and Metabolism Institute
Cleveland Clinic Foundation
Peer-Reviewers
Kanwal Anwar, MD
Elliot Endocrinology Associates
Paulo Augusto Carvalho Miranda MD, Ph D
Endocrinology and Metabolism Clinic Santa Casa BH
Cheow Peng Ooi, MBBCH, BAO, MRCPI, MSc, PhD
International Medical University, Malaysia
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Maria Luiza Caramori, MD, PhD
Dr. Caramori has received research grants from NIH, Breakthrough T1D, Bayer Pharmaceuticals, Boehringer Ingelheim, and Eli Lilly; she has received consulting fees/honorarium from Clearview Healthcare, Heart in Diabetes, Armana, Bayer AG, Bayer Pharmaceuticals, Novo Nordisk, and Up-to-date; she participates as a reviewer or editorial board member for Diabetes, KDIGO, ADA, and Up-to-date (uncompensated for Diabetes, KDIGO, and ADA)
Rodica P Busui, MD,PhD
Dr. Rodica Busui has received research grants from NIDDK (PI on R01 and U01 grants), Bayer, Lexicon Pharma, and Novo Nordisk; she has received consulting fees/honorarium from Averitas Pharma, Lexicon Pharma, Novo Nordisk, Roche, and Viatris; she serves as a member of the Board of Directors and as Associate Editor for Diabetes Care for the American Diabetes Association (uncompensated).
James Januzzi, MD
Dr. Januzzi has received research grants from Abbott Diagnostics, Applied Therapeutics, AstraZeneca, HeartFlow, and Novartis; he has received consulting fees/honorarium from Abbott, AstraZeneca, Beckman-Coulter, Boehringer-Ingelheim, Bristol-Myers, Intellia, Jana Care, Novartis, Pfizer, Merck, Roche Diagnostics and Siemens; He participates on data safety monitoring boards or endpoint committees for Abbott, Abbvie, Bayer, CVRx, Pfizer, Roche Diagnostics and Takeda and reports equity holdings in Fibrosys, Imbria Pharmaceuticals and Jana Care (uncompensated).
The following committee members who reviewed content for this activity reported relevant financial relationships:
Paulo Augusto Carvalho Miranda MD, Ph D
Dr. Miranda has received consulting fees/honorarium from Recordat, Ipsen, Eli Lilly, and Novo Nordisk; she serves as the former President and current Member of the International Committee of the Brazilian Society of Endocrinology and Metabolism (uncompensated).
The following committee members who reviewed content for this activty reported no relevant financial relationships:
Kanwal Anwar, MD; Cheow Peng Ooi, PhD
The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
IMNE Staff and Disclosures
Michelle Fisher, BS
Account Coordinator
Ms Fisher has nothing to disclose.
Amy Groves, BS (With Honors)
Business Lead
Ms Groves has nothing to disclose.
Elena Pinceti, PhD
Program Director
Dr Pinceti has nothing to disclose.
Steve Weinman, MSc, RN
Director of Accreditation
ANCC Accredited Provider Program Director
Mr Weinman has nothing to disclose.
Megan Widdows, MSc
Associate Principal Medical Writer
Ms Widdows has nothing to disclose.
Ruth Wills, PhD
Scientific Director
Dr Wills has nothing to disclose.
Supporter
This activity is managed by the Endocrine Society and the Institute for Medical and Nursing Education, Inc.
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.